Aller-Cort Shortage: What Providers and Prescribers Need to Know in 2026

Updated:

March 25, 2026

Author:

Peter Daggett

Summarize this blog with AI:

A clinical briefing on Aller-Cort (Triamcinolone nasal spray) availability in 2026. What providers need to know about supply, alternatives, and patient guidance.

Provider Briefing: Aller-Cort Availability in 2026

Your patients are asking about Aller-Cort. Many are reporting difficulty finding this popular Costco Kirkland Signature brand of Triamcinolone Acetonide nasal spray, particularly during peak allergy season. As a prescriber, understanding the current supply landscape helps you guide patients effectively and ensure continuity of care.

This briefing covers the current status of Aller-Cort and Triamcinolone nasal spray availability, clinical implications, cost considerations, and practical recommendations for your practice.

Timeline and Current Status

As of March 2026, Triamcinolone Acetonide nasal spray is not listed as being in shortage by the FDA Drug Shortage Database or the ASHP Drug Shortage Resource Center. Manufacturing and distribution of the active pharmaceutical ingredient remain uninterrupted.

What patients are experiencing with Aller-Cort specifically are localized, demand-driven stock-outs at Costco warehouse locations. This pattern is consistent with seasonal demand surges for OTC allergy medications and is amplified by Aller-Cort's limited distribution footprint (Costco-exclusive product).

Key Dates and Context

  • Triamcinolone nasal spray has been available OTC since 2014 (Nasacort Allergy 24HR Rx-to-OTC switch)
  • Aller-Cort (Kirkland Signature brand) has been available at Costco for several years as a lower-cost generic alternative
  • No manufacturing disruptions have been reported for Triamcinolone nasal spray in 2024, 2025, or early 2026
  • Seasonal stock-outs typically occur March through May and September through November, coinciding with spring and fall allergy seasons

Prescribing Implications

Because Aller-Cort and its equivalents (Nasacort, generic Triamcinolone nasal spray) are available over the counter, most patients self-manage their allergic rhinitis without a prescription. However, patient inquiries about availability may present opportunities to:

Review Treatment Appropriateness

  • Confirm the patient's diagnosis of allergic rhinitis versus other causes of nasal congestion
  • Assess whether an intranasal corticosteroid remains the best first-line treatment
  • Evaluate symptom control — patients who can't find their usual medication may be undertreated

Counsel on Therapeutic Equivalents

All OTC intranasal corticosteroids have demonstrated similar efficacy in clinical trials for allergic rhinitis. The available options include:

  • Triamcinolone Acetonide 55 mcg/spray (Nasacort, Aller-Cort, generics) — once daily
  • Fluticasone Propionate 50 mcg/spray (Flonase Allergy Relief, generics) — once or twice daily; also approved for ocular symptoms
  • Budesonide 32 mcg/spray (Rhinocort Allergy, generics) — once daily; alcohol-free formulation
  • Mometasone Furoate 50 mcg/spray (Nasonex 24HR, generics) — once daily; low systemic bioavailability

For patients with moderate-to-severe allergic rhinitis not adequately controlled by monotherapy, Azelastine/Fluticasone (Dymista) — a prescription combination of an intranasal antihistamine and corticosteroid — may offer superior symptom control.

Consider Step-Up Therapy When Indicated

Patients presenting with difficulty finding their OTC nasal spray may benefit from a clinical conversation about whether their current treatment is adequate. Consider escalation to:

  • Combination intranasal therapy (Dymista)
  • Addition of oral antihistamines (Cetirizine, Loratadine, Fexofenadine)
  • Allergen immunotherapy for patients with confirmed allergen sensitivities and inadequate response to pharmacotherapy

Availability Picture

The broader availability of Triamcinolone nasal spray and equivalent intranasal corticosteroids remains strong:

  • Aller-Cort: Costco warehouses and Costco.com only — subject to localized stock-outs during allergy season
  • Nasacort Allergy 24HR: Widely available at major pharmacy chains, grocery stores, and online retailers
  • Generic Triamcinolone nasal spray: Available at CVS, Walgreens, Walmart, and independent pharmacies
  • Fluticasone, Budesonide, Mometasone: Widely available OTC under multiple brand and generic names

Patients who specifically want the Aller-Cort brand for its lower price point ($12–$18 per bottle) should be counseled that generic Triamcinolone from other retailers typically costs $20–$22 with a discount card, and store-brand generics of other nasal steroids may be comparably priced.

Cost and Access Considerations

As OTC medications, intranasal corticosteroids are not subject to insurance formulary restrictions or prior authorization requirements. However, cost remains a factor for patients:

  • FSA/HSA eligibility: OTC allergy medications are eligible for purchase with pre-tax health accounts
  • Discount cards: GoodRx, SingleCare, and RxSaver offer significant discounts on both brand-name and generic nasal sprays
  • Patient assistance: For patients with financial hardship, NeedyMeds and RxAssist can help identify available resources
  • Prescription options: When prescribing Dymista or other prescription nasal sprays, verify insurance coverage — many plans require prior authorization or step therapy documentation

For detailed cost information, see our guide on how to help patients save money on Aller-Cort.

Tools and Resources for Your Practice

Medfinder for Providers offers tools to help clinical teams check medication availability and guide patients to pharmacies with stock. Key features include:

  • Real-time availability checking for Aller-Cort and equivalent nasal sprays by zip code
  • Price comparison across pharmacies
  • Patient-friendly resources you can share during office visits

You can also direct patients to the following educational resources:

Looking Ahead

The intranasal corticosteroid market is stable and competitive, with no anticipated supply disruptions. Key trends to watch in 2026 and beyond include:

  • Expanding OTC availability: More nasal steroids are moving from prescription to OTC status, increasing patient access
  • Generic competition: Continued generic entry is keeping prices low and availability high
  • Climate and allergy trends: Longer, more intense allergy seasons may increase demand for nasal corticosteroids, potentially driving more seasonal stock-outs at popular retailers
  • Digital pharmacy tools: Growing adoption of real-time stock-checking tools like Medfinder may help reduce the impact of localized stock-outs

Final Thoughts

While Aller-Cort specifically may be intermittently difficult to find due to its Costco-exclusive distribution, the underlying medication — Triamcinolone Acetonide nasal spray — and its therapeutic equivalents remain widely available and affordable. Providers can reassure patients, counsel on equivalent alternatives, and use this as an opportunity to review allergy treatment plans.

For practice tools and patient resources, visit Medfinder for Providers.

Is Triamcinolone nasal spray interchangeable with Fluticasone for my patients?

Yes, for the treatment of allergic rhinitis, Triamcinolone Acetonide nasal spray and Fluticasone Propionate nasal spray are considered therapeutically equivalent. Both are intranasal corticosteroids with similar efficacy profiles in clinical trials. One notable difference: Fluticasone (Flonase) is also FDA-approved for ocular allergy symptoms, which may be relevant for patients with eye involvement.

Should I write a prescription for Triamcinolone nasal spray so my patient can get insurance coverage?

Since Triamcinolone nasal spray is available OTC, most insurance plans do not cover it even with a prescription. However, some plans may cover OTC medications with a prescription, and FSA/HSA accounts can be used for OTC purchases. For patients needing insurance-covered nasal steroid therapy, prescribing Dymista (Azelastine/Fluticasone) or another prescription-only option may be more appropriate.

Are there any clinical scenarios where Triamcinolone nasal spray is preferred over other nasal steroids?

Intranasal corticosteroids are generally interchangeable for allergic rhinitis. However, Triamcinolone (Nasacort) has a scent-free, alcohol-free formula that some patients prefer. Budesonide (Rhinocort) is also alcohol-free. Fluticasone may be preferred when ocular symptoms are present. Mometasone has the lowest systemic bioavailability, which may be preferred in pediatric patients or those concerned about systemic effects.

What should I recommend for patients who can't find any OTC nasal steroid spray?

This would be unusual given the broad availability of multiple OTC nasal steroids. If a patient truly cannot find any OTC option, consider prescribing Dymista (Azelastine/Fluticasone) or a standalone intranasal antihistamine like Azelastine (Astepro), which is also now available OTC. Oral antihistamines (Cetirizine, Loratadine, Fexofenadine) can provide supplemental relief while the patient locates a nasal steroid.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast-turnaround time
Never call another pharmacy